??
簡體版
繁體版
English
 
Main Page
Diseases Encyclopedia
TCM-News
Advice From Doctor
Diet Therapy
TCM-Health Wellness
Sexual Health
Health Column
Special-featured therapy
Chinese Herbs
TCM-Acupunture
TCM-Tuina
Gufang message
Contact Us
 

China TCM web

Patients should try to come to consult us personally, for those that cannot do that, please send or fax to the professional group your recent symptoms, examination, analysis, early diagnose and case history (including patient's address, telephone number, height, weight), after discussion and diagnosis by the professional group, the treatment plan will be informed to the patient and he/she should receive treatment by postage. One can consult the professional group anytime during the treatment.
 

Contact Us
Tel: +0086 13631453379
Contact:Miss Wang
Email:yizi-ice@hotmail.com
Address:Bei Xi Liu Lu Zhan Dian Zi Bo Shan Dong China
Remittance/Payment:

>>> TCM network - Sexual Health  
Doctor Profile
    Dr. Wang Yong, character Shurun,
of Han Nationality, is born to the
Chinese  medicine  aristocratic
family,he has inherited the essence
of traditional Chinese medicine,he
uses ancient secret remedies as the
base and he complies........more
 
Gufang Introduction
    Gufang Chinese medicine
complicated diseases research center
is located at Shan Dong Province Zi
Bo City , ZhangDian Bei Xi Liu Road;
Zi Bo is situated between Lu Zhong
mountain area andLuBei champagne,
located at a unique......more
 
Full results show AIDS vaccine is of modest help
2009-10-21 【font size: Large Medium Small】  【Close
----------------------------------------------------------------------------------------------------------------------------------------

  Fresh results from the world's first successful test of an experimental AIDS vaccine confirm that it is only marginally effective.

  Yet, the findings are exciting to scientists, who think they may show how to make a better vaccine.

  The results also hint that the vaccine may work better in the general population than in those at higher risk of infection, such as gay men and intravenous drug users. It was the first time an AIDS vaccine was tested mostly in heterosexuals at average risk, and doctors have long known that how a person is exposed to HIV affects the odds of becoming infected.

  Last month, researchers announced that a two-vaccine combination cut the risk of becoming infected with HIV by more than 31 percent in a trial of more than 16,000 volunteers in Thailand.

  Full results, published online Tuesday by the New England Journal of Medicine and presented at a scientific conference in Paris, include two additional analyses that merely suggest the vaccine is beneficial, rather than providing definitive proof.

  That's mostly because so few participants became infected a€” only 125 people, 10 times less than in previous HIV vaccine trials, said Dr. Anthony Fauci, director the National Institute of Allergy and Infectious Diseases, the study's main sponsor.

  Critics had leaked one of the analyses last week, saying it showed the original results may have been a fluke. A California-based AIDS advocacy group criticized study leaders for not giving a fuller picture when they held their news conference last month.

  'The bottom line is that those results are real,' even though they are not good enough to justify using this vaccine now, said Dr. Alan Bernstein, executive director of the Global HIV Vaccine Enterprise, an alliance of governments, AIDS scientists, the World Health Organization and funders such as the Bill & Melinda Gates Foundation.

  'We, for the first time, have evidence of protection, and the nitty gritty (arguments) to me don't matter a damn,' Bernstein said.

  Other scientists who, like Bernstein, had no role in the trial, agreed.

  'It's a consistent story. There seems to be some effect. And I think it is an important study. It redirects the field to look at a different kind of vaccine and different kinds of immune responses' than what have been the focus in the past, said Dr. Lawrence Corey of the University of Washington. He heads the HIV Vaccine Trials Network, an international group of scientists who test vaccines.

  The Thailand Ministry of Public Health conducted this trial, which used vaccines made from strains of HIV common in Thailand. They are ALVAC, made by Sanofi Pasteur, and AIDSVAX, originally developed by VaxGen Inc. and now held by the nonprofit Global Solutions for Infectious Diseases. The vaccines are not made from whole virus and cannot cause HIV infection.

  The combo was tested in HIV-negative Thai men and women ages 18 to 30 at average risk of becoming infected. Half received four doses of ALVAC and two of AIDSVAX over six months; the rest received dummy shots. All were given condoms and counseling, and were followed for three years after vaccination ended.

  New infections occurred in 51 of the 8,197 given vaccine and in 74 of the 8,198 who received dummy shots. That worked out to a 31 percent lower risk of infection for the vaccine group.

  In a smaller analysis of just the 12,452 participants who received all six shots exactly on schedule, there were 86 infections a€” 36 in the vaccine group and 50 in those given dummy shots.

  The vaccine appeared nearly twice as effective among those at low or moderate risk for HIV, versus people who share needles, have contact with prostitutes or engage in other risky behaviors. But those results were not statistically significant, meaning they could have occurred by chance.

  'Perhaps the requirements for protection against transmission in low-risk heterosexual persons are considerably different or less stringent,' Dr. Raphael Dolin of Beth Israel Deaconess Medical Center in Boston wrote in an editorial published by the medical journal.

  Evidence of vaccine protection emerged at six months to one year and then seemed to wane, although this trend, too, was not statistically significant.

  'It would suggest the vaccine is not that potent,' although there were too few infections in either group to make solid comparisons, said Dr. Seth Berkley, president of the International AIDS Vaccine Initiative, which helps develop and assess potential vaccines.

  The U.S. Army has long had a partnership with Thailand and its Royal Army to test vaccines and medicines to protect troops and the general population. Soaring rates of HIV infection a decade ago led the Thai government to make vaccine research a high priority. Some previous experimental AIDS vaccines have been tested in Thailand as well.

 

?
 

guanliyuan
© 2019 TCM network All rights reserved
RecordNumber:(ICP): LuICPBei05008738
彩票状元专家专栏 镇远县| 美姑县| 新乐市| 冀州市| 上高县| 库尔勒市| 利津县| 通江县| 萍乡市| 保靖县| 确山县| 自贡市| 依安县| 会同县| 镇坪县| 宽城| 大连市| 南康市| 北海市| 土默特左旗| 肃南| 志丹县| 定日县| 江永县| 育儿| 资兴市| 轮台县| 黎平县| 翁牛特旗| 孟津县| 衡阳市| 瑞昌市| 哈巴河县| 墨江| 南漳县| 轮台县| 旬邑县| 什邡市|